Reveal the ‘why’ behind treatment decisions and understand the patient journey.

Patient Chart Dynamix™ audits help you develop patient profiles and uncover opportunities.

• Capture data not available in claims by tapping into rigorous analysis of large-scale patient chart audits
• Understand differences between stated and actual treatment patterns with specialists’ attitudinal & demographic data
• See how clinical trial populations compare to real patient management patterns and identify secondary endpoints that will allow for differentiation

Methodology:

• Insights are based on patient-level data gathered through collaboration with specialty physicians who provide details on clinical and non-clinical patient demographics, along with rationale for treatment choices.

Sample Size & Frequency:

Uncover the patient’s voice throughout their disease and treatment journey.

Patient Voice Dynamix™ audits help you understand patient experiences and their perceptions. 

• The patient perspective on unmet needs and the attributes most desired in emerging therapies
• Differences between patient and physician views on disease severity, treatment priorities, and satisfaction
• How patient experiences and expectations evolve across the treatment continuum

Methodology:

• Insights are based on analyses of qualitative interviews and quantitative data collected through online surveys of patients directly recruited via specialists and leading patient advocacy groups, ensuring valid, credible, and representative responses.

Sample Size & Frequency:

Sample sizes vary based on indication and inclusion criteria

Independently assess launches and benchmark history of analogs.

Monthly KPI benchmarking of newly launched products (first 18 months), augmented by 6 quarterly deep dives, including qualitative interviews, focusing on:

• Drivers and barriers of uptake
• Promotional activity
• Patient types gravitating to the launch brand
• Competitive analyses

Methodology:

• Insights are based on analyses of quantitative data from an online survey of physicians recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents.

Sample Size & Frequency:

Gain an unbiased perspective of the market and its potential.

Market Dynamix™ reports blend data from specialists and leading KOLs.

• Market size and current treatment approaches
• What is needed to support early adoption and optimization of an asset
• Unmet needs and attributes most desired in new therapeutics
• Expert opinions on the likely disruption introduced by pipeline agents

Methodology:

• Insights are based on analyses of quantitative data from an online survey of specialists, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents and select KOLs.

Sample Size & Frequency:

Add context to trending topics and gauge the impact of disruptive events.

Special Topix™ reports on trending events and topics of interest in specialty markets.

• Gain an objective perspective and context into the real issues influencing market shifts
• Understand the prescriber’s perspective on trending topics and disruptive events
• Gather insights on initial and potential lasting impacts on existing commercial brands
• Deep dive into the mindset of fellows & residents

Methodology:

• Insights are based on data from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size & Frequency:

• Report cadence and deliverable depend upon current event/topic being evaluated.